CRBU
Caribou Biosciences·NASDAQ
--
--(--)
--
--(--)
3.93 / 10
Netural
Fund‑flow rating is good (7.86/10) with strong inflows across block, medium, large and extra‑large investors, though small investors are net out. Analyst coverage shows a single Buy recommendation, but historical performance is negative. Overall sentiment is bullish yet tempered by weak fundamentals.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-09
InstitutionEvercore ISI Group
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of CRBU?
- CRBU holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.93/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
